State of Tennessee, Department of Treasury’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.51M | Hold |
37,524
| – | – | 0.01% | 1048 |
|
|
2025
Q4 | $1.5M | Sell |
37,524
-4,921
| -12% | -$387K | ﹤0.01% | 1040 |
|
|
2025
Q3 | $3.53M | Sell |
42,445
-217
| -0.5% | -$15.7K | 0.01% | 684 |
|
|
2025
Q2 | $3.13M | Sell |
42,662
-1,108
| -3% | -$80.3K | 0.01% | 712 |
|
|
2025
Q1 | $5M | Buy |
43,770
+2,300
| +6% | +$140K | 0.02% | 530 |
|
|
2024
Q4 | $2.09M | Sell |
41,470
-2,312
| -5% | -$121K | 0.01% | 889 |
|
|
2024
Q3 | $2.03M | Sell |
43,782
-3,016
| -6% | -$107K | 0.01% | 928 |
|
|
2024
Q2 | $1.52M | Sell |
46,798
-1,922
| -4% | -$52.6K | 0.01% | 969 |
|
|
2024
Q1 | $1.23M | Sell |
48,720
-4,037
| -8% | -$95.4K | ﹤0.01% | 1064 |
|
|
2023
Q4 | $1.71M | Hold |
52,757
| – | – | 0.01% | 939 |
|
|
2023
Q3 | $1.44M | Sell |
52,757
-1,943
| -4% | -$56.2K | 0.01% | 897 |
|
|
2023
Q2 | $1.22M | Sell |
54,700
-14,636
| -21% | -$337K | 0.01% | 1079 |
|
|
2023
Q1 | $1.5M | Sell |
69,336
-3,300
| -5% | -$72.3K | 0.01% | 950 |
|
|
2022
Q4 | $1.48M | Hold |
72,636
| – | – | 0.01% | 965 |
|
|
2022
Q3 | $1.86M | Buy |
72,636
+8,050
| +12% | +$215K | 0.01% | 846 |
|
|
2022
Q2 | $1.54M | Sell |
64,586
-12,347
| -16% | -$269K | 0.01% | 921 |
|
|
2022
Q1 | $1.73M | Buy |
76,933
+763
| +1% | +$16.2K | 0.01% | 944 |
|
|
2021
Q4 | $1.51M | Sell |
76,170
-945
| -1% | -$19.2K | 0.01% | 982 |
|
|
2021
Q3 | $1.52M | Buy |
77,115
+6,360
| +9% | +$133K | 0.01% | 964 |
|
|
2021
Q2 | $1.56M | Buy |
70,755
+3,336
| +5% | +$74.2K | 0.01% | 992 |
|
|
2021
Q1 | $1.6M | Buy |
67,419
+131
| +0.2% | +$3.5K | 0.01% | 947 |
|
|
2020
Q4 | $1.76M | Buy |
67,288
+6,418
| +11% | +$135K | 0.01% | 844 |
|
|
2020
Q3 | $1.06M | Sell |
60,870
-2,773
| -4% | -$44.2K | ﹤0.01% | 926 |
|
|
2020
Q2 | $1.07M | Sell |
63,643
-2,517
| -4% | -$35.4K | 0.01% | 934 |
|
|
2020
Q1 | $787K | Sell |
66,160
-14,717
| -18% | -$182K | ﹤0.01% | 972 |
|
|
2019
Q4 | $979K | Sell |
80,877
-4,210
| -5% | -$58.6K | ﹤0.01% | 1064 |
|
|
2019
Q3 | $1.2M | Buy |
85,087
+11,809
| +16% | +$145K | 0.01% | 990 |
|
|
2019
Q2 | $817K | Sell |
73,278
-11,087
| -13% | -$124K | ﹤0.01% | 1078 |
|
|
2019
Q1 | $990K | Buy |
84,365
+11,626
| +16% | +$144K | ﹤0.01% | 1036 |
|
|
2018
Q4 | $972K | Buy |
72,739
+8,412
| +13% | +$111K | 0.01% | 1008 |
|
|
2018
Q3 | $902K | Sell |
64,327
-1,066
| -2% | -$14.9K | ﹤0.01% | 1102 |
|
|
2018
Q2 | $1.03M | Sell |
65,393
-2,286
| -3% | -$39.8K | 0.01% | 1065 |
|
|
2018
Q1 | $1.11M | Buy |
+67,679
| New | +$1.25M | 0.01% | 1010 |
|
Other funds holding CORT
ISL
VPM
VCM
PA
State of Tennessee, Department of Treasury's CORT Position: Q1 2026 in Review
State of Tennessee, Department of Treasury held its Corcept Therapeutics (CORT) position steady in Q1 2026 at 37,524 shares worth $1.51M. The position accounts for 0.01% of the portfolio, ranked #1048.
State of Tennessee, Department of Treasury first reported a position in CORT in Q1 2018 and has held it in 33 quarters since. The position peaked at $5M in Q1 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.
- State of Tennessee, Department of Treasury held 37,524 shares of Corcept Therapeutics worth $1.51M as of Q1 2026.
- State of Tennessee, Department of Treasury left its Corcept Therapeutics share count unchanged in Q1 2026.
- Corcept Therapeutics made up 0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #1048 holding.
- State of Tennessee, Department of Treasury first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 33 quarters since.
- State of Tennessee, Department of Treasury's Corcept Therapeutics position peaked at $5M in Q1 2025.
- 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.
Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.